GO
Loading...

Bristol-Myers Squibb Co

More

  • Early movers: NKE, DD, PFE, GM, INTC, BMY & more Friday, 27 Jun 2014 | 7:33 AM ET
    Traders work on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • NEW YORK, June 25- U.S. stock investors ignored weak economic data and pushed equities higher on Wednesday, as drugmakers' shares rose and a Supreme Court ruling lifted major broadcaster stocks, while German bond yields hit the year's low on safe-haven bids.

  • US STOCKS-Wall St gains with drugmakers, broadcasters Wednesday, 25 Jun 2014 | 5:09 PM ET

    *Monsanto rallies on outlook and stock-repurchase plans. *CBS shares jump after Supreme Court ruling. Shares of CBS jumped 6.2 percent to $62.48 after the U.S. Supreme Court ruled that online TV startup Aereo Inc violates copyright law by using tiny antennas to provide subscribers with broadcast network content via the Internet.

  • US stocks finish higher; S&P 500 near record close Wednesday, 25 Jun 2014 | 4:51 PM ET
    Trader on the floor of the New York Stock Exchange.

    U.S. stocks rose on Wednesday after mixed economic reports.

  • US STOCKS-Wall St rises slightly despite weak GDP report Wednesday, 25 Jun 2014 | 1:40 PM ET

    *Monsanto rallies after results; General Mills lower. *Medical Action almost doubles, Owens& Minor to buy.

  • Midday movers: CBS, HBI, MON, BMY, MDCI & More Wednesday, 25 Jun 2014 | 11:28 AM ET

    Take a look at some of Wednesday's midday movers.

  • US STOCKS-Wall St edges higher despite weak GDP report Wednesday, 25 Jun 2014 | 10:27 AM ET

    *Monsanto rallies after results, General Mills lower. NEW YORK, June 25- U.S. stocks edged higher on Wednesday as investors continued to find value in equities over other asset classes despite the latest economic data coming in below expectations.

  • *Investors watching Iraq violence; crude prices rise. *Monsanto rallies after results, General Mills lower. NEW YORK, June 25- U.S. stock index futures pointed to a lower open on Wednesday as the latest economic data came in below expectations, giving investors further reasons to take profits amid ongoing tension in Iraq.

  • US STOCKS-Futures flat after decline, GDP data awaited Wednesday, 25 Jun 2014 | 7:39 AM ET

    *Investors watching Iraq tension, crude oil rises early. Durable goods orders, also due at 8:30 a.m., are seen as flat in May, while a June read on service sector business activity from financial data firm Markit is seen as essentially unchanged from May.

  • June 24- A late-stage trial testing Bristol-Myers Squibb Co's cancer immunotherapy nivolumab in advanced melanoma patients was halted early after it was determined that the drug was likely to prolong survival, the company said on Tuesday.

  • Check out which companies are making headlines after the bell Tuesday.

  • *$46 bln offer from AbbVie rejected as undervaluing group. LONDON, June 23- Shire flagged the promise of existing and new drugs on Monday as evidence that AbbVie's $46 billion offer undervalued the company, the latest British firm to be targeted by a U.S. group seeking lower taxes.

  • *$46 bln offer from AbbVie rejected as undervaluing group. LONDON, June 23- Shire flagged the promise of existing and new drugs on Monday as evidence that AbbVie's $46 billion offer undervalued the company, the latest British firm to be targeted by a U.S. group seeking lower taxes.

  • *$46 bln offer from AbbVie rejected as undervaluing group. LONDON, June 23- Shire is to take a leaf out of AstraZeneca's playbook by giving long-range forecasts for its drugs as it seeks to convince shareholders that AbbVie's $46 billion offer undervalues the business.

  • *$46 bln offer from AbbVie rejected as undervaluing group. LONDON, June 23- Shire is to take a leaf out of AstraZeneca's playbook by giving long-range forecasts for its drugs as it seeks to convince shareholders that AbbVie's $46 billion offer undervalues the business.

  • *Shire rejects AbbVie offer valued at 46.26 pounds a share. LONDON, June 20- British drugmaker Shire has rejected a 27 billion-pound takeover offer from AbbVie, the latest attempt by a U.S. healthcare firm to tap into lower tax rates abroad via an acquisition.

  • Early movers: DRI, ORCL, BAC, TWTR, S, SHPG & more Friday, 20 Jun 2014 | 7:36 AM ET
    Traders on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • LONDON, June 20- British drugmaker Shire has rejected a 27 billion-pound takeover offer from AbbVie, the latest attempt by a U.S. healthcare firm to tap into the London- listed group's low tax rate. Abbvie's takeover offer proposed creating a new U.S.-listed holding company with a UK tax domicile in a so-called "inversion" move.

  • NEW YORK, June 20- In the race to find a faster cure for hepatitis C, Bristol-Myers Squibb Co said it will test its experimental antiviral drug combination with Gilead Sciences Inc's blockbuster drug Sovaldi, hoping to cut treatment time to four weeks.

  • *Shire expecting to receive approaches, taps Citi- sources. LONDON, June 17- Shares in Shire hit a record high on Tuesday on expectations of a takeover as dealmaking sweeps the drugs sector, after Reuters reported the group had hired investment bank Citi as a defence adviser. Shire and Citi declined to comment.